Imaging and biomarkers in early alzheimer's disease and mild cognitive impairment

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

A major focus of research on aging and dementia pertains to the prediction of future cognitive decline. Toward this end, several longitudinal studies are under way that are designed to explore early predictors of cognitive impairment. Neuroimaging techniques and biomarkers have shown promise in this application. Ultimately, it is likely that the use of a combination of neuroimaging and chemical biomarkers will be involved in predicting the development of dementia and Alzheimer's disease (AD).

Original languageEnglish (US)
Pages (from-to)438-441
Number of pages4
JournalClinical pharmacology and therapeutics
Volume86
Issue number4
DOIs
StatePublished - Oct 1 2009

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Imaging and biomarkers in early alzheimer's disease and mild cognitive impairment'. Together they form a unique fingerprint.

  • Cite this